Celsion Corporation, a biotechnology drug development company, has appointed Jeffrey Church as vice president and chief financial officer (CFO).
Church brings more than 30 years of experience in financial management to Celsion, the majority of which are as a CFO. Prior to Celsion, he served as CFO for Alba Therapeutics, Novavax, GenVec, and Meridian Medical Technologies. Church has extensive experience in corporate finance, mergers and acquisitions, investor and Wall Street relations, and SEC reporting. He is a certified public accountant (CPA) and earned a BSc in Accounting, Summa Cum Laude from the University of Maryland.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more